Before deciding, separate verified evidence, assumptions that could be tested, and genuine unknowns. The decision is about whether the unknowns are acceptable at this price.
10 min read · Level 4
I think a decision memo that contains no unknowns is either about a very late-stage company or not being honest. Naming what nobody can know yet does not weaken the case for investing; it shows exactly what the investor is being paid to accept.
After diligence, sort every important claim into one of three groups:
Group What it means Example Evidence verified from independent sources retention confirmed from billing data Testable assumption could be checked but has not been customers will accept a 20% price increase Unknown cannot be known before investing whether a large competitor enters the market
Then ask three questions:
A decision table for one company:
Evidence (5) ARR, retention, founder backgrounds, IP ownership, cash Testable (3) pricing power, sales cycle at scale, hiring pace Unknown (2) competitor response, regulatory change Load-bearing pricing power (testable), competitor response (unknown)
Because investors often treat assumptions as evidence once they have been repeated enough times in meetings. Sorting claims into groups makes visible how much of the decision rests on things nobody has checked.
It also shows where more diligence would actually change the decision, and where it would only feel reassuring.
Educational, not personalised financial advice. Nothing in the Investor Academy is a recommendation to buy, sell or hold anything — what is right for you depends on your own circumstances and the rules where you live.
Deciding what to do next.
Pricing power is testable and load-bearing. The investor asks the company for results of last year's price change on existing customers and for three calls with customers who received it. The data shows churn did not rise after a 15% increase - the assumption becomes evidence.
Competitor response remains unknown and cannot be tested. The investor accepts it but lowers their walk-away price to reflect it, and records it as the main risk in the decision record.
Continuing diligence on claims that do not affect the decision, while leaving the load-bearing assumptions untested.
Label each important claim as evidence, testable assumption or unknown.
Mark the claims that would change the decision if wrong.
Focus remaining diligence there.
Decide whether the price compensates for the risks you cannot remove.
At the end of diligence, before making an investment decision.
Do not expect to convert every unknown into evidence; early-stage investing always involves accepting some.
Management researchers Rita McGrath and Ian MacMillan described discovery-driven planning, which asks ventures to list assumptions explicitly and convert them into knowledge through checkpoints, because plans under uncertainty are dominated by untested assumptions.
Making assumptions explicit is the first step to testing the ones that matter.
Create a free account to read the rest and apply it to your own investing.